IP Library › Granted Patent US 12,459,985
Granted Patent B2
US 12,459,985 · App. 16/463,313 · Granted Nov 4, 2025

G-protein-coupled receptor internal sensors

Inventors: Lin Tian (Davis, CA); Tommaso Patriarchi (Davis, CA); Ruqiang Liang (Davis, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
C07K14/723A61K49/0008A61K49/0056G01N33/542G01N33/74C07K2319/60G01N2333/726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,459,985
App. No.
16/463,313
Granted
Nov 4, 2025
Kind
B2
Abstract

Provided are circularly permuted fluorescent protein sensors useful to integrate into the third intracellular loop of a G protein-coupled receptor (GPCR). Also provided are GPCRs having a circularly permuted fluorescent protein sensor integrated into its third intracellular loop and methods of using such GPCRs, e.g., to screen for GPCR agonists and antagonists and to monitor activation of GPCRs both in vitro and in vivo.

Claims (49)

1 . A class A type G protein-coupled receptor (GPCR) comprising a fluorescent sensor, the sensor comprising the following polypeptide structure:

L1-cpFP-L2, wherein:

(1) L1 comprises a peptide linker LSSLI (SEQ ID NO:73);

(2) cpFP comprises a circularly permuted beta barrel fluorescent protein, wherein the circularly permuted N-terminus is positioned within beta strand seven of a non-permuted beta barrel fluorescent protein; and

(3) L2 comprises a peptide linker NHDQL (SEQ ID NO:74), and

wherein the GPC rises SEQ ID NO. 165;

wherein the circularly permuted fluorescent protein is from a fluorescent protein having at least 90% sequence identity to a non-permuted fluorescent protein selected from the group consisting of SEQ ID NO's: 1-14 or wherein the circularly permuted fluorescent protein has at least 90% sequence identity to a circularly permuted fluorescent protein selected from the group consisting of SEQ ID NOs: 15-18;

wherein the insertion site for the sensor is located in the third intracellular loop of SEQ ID NO: 165;

wherein the insertion site in the GPCR for the sensor is located after amino acid residue 228 of SEQ ID NO: 165; and

wherein the insertion site for the sensor is located between Q229 and L230, is located between S246 and Q247, replaces the amino acid residues between R228 and K267, or replaces the amino acid residues between L230 and F264.

2 . The GPCR of claim 1 , wherein L1 comprises QLQKIDLSSLI (SEQ ID NO: 75).

3 . The GPCR of claim 1 , wherein the circularly permuted fluorescent protein is from a fluorescent protein having at least 90% sequence identity to a non-permuted fluorescent protein selected from the group consisting of SEQ ID NOs: 1-14.

4 . The GPCR of claim 1 , wherein the circularly permuted fluorescent protein has at least 90% sequence identity to a circularly permuted fluorescent protein selected from the group consisting of SEQ ID NOs: 15-18.

5 . A polynucleotide encoding the GPCR of claim 1 .

6 . An expression cassette comprising the polynucleotide of claim 5 .

7 . A vector comprising the polynucleotide of claim 5 .

8 . A cell comprising the GPCR of claim 1 .

9 . A transgenic animal comprising the GPCR of claim 1 .

10 . A method of detecting binding of a ligand to a GPCR, comprising:

a) contacting the ligand with a GPCR of claim 1 under conditions sufficient for the ligand to bind to the GPCR; and

b) determining a change in an optics signal from the sensor integrated into the third intracellular loop of the GPCR, wherein a detectable change in fluorescence signal indicates binding of the ligand to the GPCR.

11 . A method of screening for binding of a ligand to a GPCR, comprising:

a) contacting a plurality of members from a library of ligands with a plurality of GPCRs under conditions sufficient for the ligand members to bind to the GPCRs, wherein the plurality of GPCRs are arranged in an array of predetermined addressable locations, wherein each GPCR in the plurality of GPCRs is independently a GPCR of claim 1 ; and

b) determining a change in one or more optics signals from the sensor integrated into the third intracellular loop of the plurality GPCRs, wherein a detectable change in the one or more fluorescence signals indicates binding of one or more members of the library of ligands to at least one QPCR of the plurality of GPCRs.

12 . A class A type G protein-coupled receptor (GPCR) comprising a fluorescent sensor, the sensor comprising the following polypeptide structure:

L1-cpFP-L2, wherein:

(1) L1 comprises a peptide linker LSSLI (SEQ ID NO:73);

(2) cpFP comprises a circularly permuted beta barrel fluorescent protein, wherein the circularly permuted N-terminus is positioned within beta strand seven of a non-permuted beta barrel fluorescent protein; and

(3) L2 comprises a peptide linker NHDQL (SEQ ID NO:74), and

wherein the GPCR is a GPCR selected from the group consisting of ADRB1 (B1AR) adrenoceptor beta 1, ADORA1 (A1AR) adenosine A1 receptor, ADORA2A (A2AR) adenosine A2a receptor, a mu (μ)-type opioid receptor (MOR), a kappa (η)-type opioid receptor (KOR), a dopamine receptor type-1 (DRD1), a dopamine receptor type-2 (DRD2), a dopamine receptor type-4 (DRD4), a 5-hydroxy-tryptamine receptor 2A (5-HT2A), and MTNR1B (MT2) melatonin receptor 1B;

wherein the circularly permuted fluorescent protein is from a fluorescent protein having at least 90% sequence identity to a non-permuted fluorescent protein selected from the group consisting of SEQ ID NO's: 1-14 or wherein the circularly permuted fluorescent protein selected from the group consisting of SEQ ID NOs: 15-18;

wherein the insertion site for the sensor replaces the third intracellular loop of the GPCR; and

wherein:

i) when the GPCR is DRD1 then the insertion site for the sensor replaces the amino acid residues of the receptor between RIYRIAQK (SEQ ID NO:52) and KRETKVLK (SEQ ID NO:53) where the N-terminus of the sensor abuts the amino acid sequence of RIYRIAQK (SEQ ID NO:52) of the receptor and the C-terminus of the sensor abuts the amino acid sequence KRETKVLK (SEQ ID NO:53) of the receptor;

ii) when the GPCR is B1AR then the insertion site for the sensor replaces the amino acid residues of the receptor between RVFREAQK (SEQ ID NO:54) and REQKALKT (SEQ ID NO:55) where the N-terminus of the sensor abuts the amino acid sequence of RVFREAQK (SEQ ID NO: 54) of the receptor and the C-terminus of the sensor abuts the amino acid sequence REQKALKT (SEQ ID NO:55) of the receptor;

iii) when the GPCR is DRD2 then the insertion site for the sensor replaces the amino acid residues of the receptor between IVLRRRRK (SEQ ID NO:58) and QKEKKATQ (SEQ ID NO:59) where the N-terminus of the sensor abuts the amino acid sequence of IVLRRRRK (SEQ ID NO: 58) of the receptor and the C-terminus of the sensor abuts the amino acid sequence QKEKKATQ (SEQ ID NO:59) of the receptor;

iv) when the GPCR is DRD4 then the insertion site for the sensor replaces the amino acid residues of the receptor between RGLQRWEV (SEQ ID NO:60) and GRERKAMR (SEQ ID NO:61) where the N-terminus of the sensor abuts the amino acid sequence of RGLQRWEV (SEQ ID NO: 60) of the receptor and the C-terminus of the sensor abuts the amino acid sequence GRERKAMR (SEQ ID NO:61) of the receptor;

v) when the GPCR is KOR then the insertion site for the sensor replaces the amino acid residues of the receptor between LMILRLKS (SEQ ID NO:62) and REKDRNLR (SEQ ID NO:63) where the N-terminus of the sensor abuts the amino acid sequence of LMILRLKS (SEQ ID NO:62) of the receptor and the C-terminus of the sensor abuts the amino acid sequence REKDRNLR (SEQ ID NO:63) of the receptor;

vi) when the GPCR is MOR then the insertion site for the sensor replaces the amino acid residues of the receptor between LMILRLKS (SEQ ID NO:62) and KEKDRNLR (SEQ ID NO:64) where the N-terminus of the sensor abuts the amino acid sequence of LMILRLKS (SEQ ID NO:62) of the receptor and the C-terminus of the sensor abuts the amino acid sequence KEKDRNLR (SEQ ID NO:64) of the receptor;

vii) when the GPCR is A2AR then the insertion site for the sensor replaces the amino acid residues of the receptor between RIYQIAKR (SEQ ID NO:65) and REKRFTFV (SEQ ID NO:66) where the N-terminus of the sensor abuts the amino acid sequence of RIYQIAKR (SEQ ID NO:65) of the receptor and the C-terminus of the sensor abuts the amino acid sequence REKRFTFV (SEQ ID NO:66) of the receptor;

viii) when the GPCR is MT2 then the insertion site for the sensor replaces the amino acid residues of the receptor between VLVLQARR (SEQ ID NO:67) and KPSDLRSF (SEQ ID NO:68) where the N-terminus of the sensor abuts the amino acid sequence of VLVLQARR (SEQ ID NO: 67) of the receptor and the C-terminus of the sensor abuts the amino acid sequence KPSDLRSF (SEQ ID NO:68) of the receptor;

ix) when the GPCR is 5-HT2A then the insertion site for the sensor replaces the amino acid residues of the receptor between LTIKSLOK (SEQ ID NO:69) and NEQKACKV (SEQ ID NO:70) where the N-terminus of the sensor abuts the amino acid sequence of LTIKSLOK (SEQ ID NO:69) of the receptor and the C-terminus of the sensor abuts the amino acid sequence NEQKACKV (SEQ ID NO:70) of the receptor;

x) when the GPCR is A1AR then the insertion site for the sensor replaces the amino acid residues of the receptor between RVYVVAKR (SEQ ID NO:71) and SREKKAAK (SEQ ID NO:72) where the N-terminus of the sensor abuts the amino acid sequence of RVYVVAKR (SEQ ID NO: 71) of the receptor and the C-terminus of the sensor abuts the amino acid sequence SREKKAAK (SEQ ID NO:72) of the receptor.

13 . A method of detecting binding of a ligand to a GPCR, comprising:

a) contacting the ligand with a GPCR of claim 12 under conditions sufficient for the ligand to bind to the GPCR; and

b) determining a change in an optics signal from the sensor integrated into the third intracellular loop of the GPCR, wherein a detectable change in fluorescence signal indicates binding of the ligand to the GPCR.

14 . A method of screening for binding of a ligand to a GPCR, comprising:

a) contacting a plurality of members from a library of ligands with a plurality of GPCRs under conditions sufficient for the ligand members to bind to the GPCRs, wherein the plurality of GPCRs are arranged in an array of predetermined addressable locations, wherein each GPCR in the plurality of GPCRs is independently a GPCR of claim 12 ; and

b) determining a change in one or more optics signals from the sensor integrated into the third intracellular loop of the plurality GPCRs, wherein a detectable change in the one or more fluorescence signals indicates binding of one or more members of the library of ligands to at least one GPCR of the plurality of GPCRs.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2020
From: TIAN, LIN; PATRIARCHI, TOMMASO; LIANG, RUQIANG
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 053028/0176 →
Continuity (3)
Provisional Application 62513991 · Jun 1, 2017
Provisional Application 62426173 · Nov 23, 2016
Related Publication 20210101960A1 · Apr 8, 2021
References Cited (25)
US 10174101B2 · Jazayeri-Dezfuly · 2019 [cited by examiner]
US 20070161062A1 · Tacke et al. · 2007 [cited by applicant]
US 20120034691A1 · Looger et al. · 2012 [cited by applicant]
US 20130332133A1 · Horn et al. · 2013 [cited by applicant]
US 20150226755A1 · Ai et al. · 2015 [cited by applicant]
US 20160229899A1 · Auldridge et al. · 2016 [cited by applicant]
US 20230384333A1 · Dong et al. · 2023 [cited by applicant]
WO 2015106067A2 · 2015 [cited by applicant]
WO 2019062744 · 2019 [cited by applicant]
WO 2022081631A1 · 2022 [cited by applicant]
Duffet et al. A genetically encoded sensor for in vivo imaging of Orexin neuropeptides.(Nature Meth, 2022, 19:231-241 (Year: 2022). [cited by examiner]
Patriarchi et al. Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors (Science, 2018, 360:1-8) (Year: 2018). [cited by examiner]
Extended European Search Report in European Application No. 17873415.8 mailed Jun. 17, 2020, 7 pages. [cited by applicant]
International Search Report and Written Opinion corresponding to PCT/US2017/062993 mailed Apr. 5, 2018. [cited by applicant]
Alicea et al., “Structure of the [cited by applicant]
Dong, “Psychedelic-inspired drug discovery using an engineered biosensor”, Cell, 2021, 184, 1-33. [cited by applicant]
Dunlap, “Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogs Through Structure-Activity Relationship Studies”, J Med Chem 2020, 63, 3, 1142-1155. [cited by applicant]
Marvin et al. “A genetically encoded, high-signal-to-noise maltose sensor,” Proteins 2011, 79, 3025-3036. [cited by applicant]
Marvin et al. “An optimized fluorescent probe for visualizing glutamate neurotransmission,” Nat. Methods, 2013, 10, 2, 162-170. [cited by applicant]
Kostyuk, “Circularly Permuted Fluorescent Protein-Based Indicators: History, Principles, and Classification”, International Journal of Molecular Sciences, 2019, 20, 4200, 1-37. [cited by applicant]
Patriarchi, “Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors”, Science 2019, 360, 6396, 1-22. [cited by applicant]
International Search Report and Written Opinion corresponding to PCT/US2021/054669 mailed Mar. 21, 2022, 15 pages. [cited by applicant]
Kim, “Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor”, Cell, 2020, 182, 6, 1574-1588. [cited by applicant]
López-Giménez, “Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways”, in Inflammation-Associated Depression: Evidence, Mechansims and Implications:, 2017, Springer International Publishing, 36, 45-73. [cited by applicant]
Ly, “Psychedelics Promote Structural and Functional Neural Plasticity”, Cell. Rep. 2018, 23, 3170-3182. [cited by applicant]